Up 40%: Is This Red-Hot Growth Stock Still a Buy?
This small-cap biotech stock is surging. Time to buy?
Down 75%. Is Agenus Stock a Buy on the Dip?
Wall Street analysts who watch the cancer drug developer closely think it could rocket higher.
2 Stocks That Could More Than Double Your Money, According to Wall Street: Are They Buys Now?
These stocks could rocket higher, but they also present significant risks.
Agenus (AGEN) Q4 2023 Earnings Call Transcript
AGEN earnings call for the period ending December 31, 2023.
Why Agenus Stock Plummeted by Nearly 30% on Its Stock Split News Today
The company hopes to engineer a 1-for-20 reverse stock split.
2 Small Cap Stocks That Could Go Parabolic in 2024, According to Wall Street
These two biotech stocks could be poised for a trend reversal.
3 Magnificent Growth Stocks to Buy on the Dip
These three biotech stocks are attractive buys right now.
Following a tumultuous performance year, the biotechnology sector is steadily regaining traction once again, with investors starting to reveal a somewhat bullish sentiment despite having to endure macroeconomic...